November/December 2019

 

In this Issue

The Retina Pipeline

The Future of Retina and the Latest Data

  • Issue

  • Insert

  • Insert

  • Supplement

  • Supplement

 
View the E-Dition

UP FRONT

Medical Editors’ Page

The Future of Retina

By Allen C. Ho, MD; and Robert L. Avery, MD

VISUALLY SPEAKING

Optic Disc Melanocytoma

By Kumar Saurabh, MD, MS; and Rupak Roy, MD, MS

MEDICAL RETINA

Silicone Oil Droplets After Bevacizumab Intravitreal Injection

Although this rare occurrence is not harmful, patients and clinicians should be educated on the potential sequelae following anti-VEGF treatment.

By Eric K. Chin, MD; and David R.P. Almeida, MD, MBA, PhD

A Choroidal Mass: An Unusual Metastasis With Unusual Treatment

Choroidal metastasis is rare in individuals with renal cancer.

By Jordana G. Fein, MD, MS; Heeral R. Shah, MD; Komal B. Desai, MD; Taylor Lind; and Uma Desai

FEATURES

Phase 3 in Retina: The Trials to Know

This review will help you understand where several potentially important studies stand.

By Michael Ammar, MD; and Jason Hsu, MD

Reframing the Retina Pipeline

By moving beyond thinking of the pipeline as which drug is in which phase, we can take a fresh perspective on therapeutic candidates in development.

By Pravin U. Dugel, MD

The Neovascular AMD Pipeline

What might the future of wet AMD therapy look like?

By Priyatham (Prithu) S. Mettu, MD

Looking to the Future of Gene Therapy in Ophthalmology

In a symposium ahead of the AAO Annual Meeting, speakers updated attendees on the status of the field.

By Kourous A. Rezaei, MD

The Uveitis Pipeline

Take a look at what’s next in uveitis.

With Steven Yeh, MD

The Future of Home-Based OCT for Retina Patients

Products in the pipeline could improve outcomes and reduce burdens on patients and physicians.

By John B. Miller, MD; and Rebecca Zeng, BA; With Sidebar Commentary by Judy E. Kim, MD

Gene Therapy Approach Demonstrated Safety With Durable Effect in Interim Wet AMD Trial Results

A dose-dependent increase in protein expression was noted in interim results, with lasting effect in higher doses.

By Jeffrey S. Heier, MD; Allen C. Ho, MD; and Robert L. Avery, MD

Intravitreal In-Office Anti-VEGF Gene Therapy

An update on ADVM-022 and the OPTIC trial.

By Szilárd Kiss, MD

MEETING MINUTES

ARDS Meeting Minutes

By Yale L. Fisher, MD; and Hugo Quiroz-Mercado, MD; Summarized by Luis A. Gonzalez, MD, MPH

VBS Fellows’ Program: Primer on Inherited Retinal Diseases

A lecture by Stephen Tsang, MD, PhD, explored progress in this burgeoning field.

By James Lin, MD
 

Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

Scott Krzywonos
Editor-in-Chief
484-581-1880
skrzywonos@bmctoday.com

Janet Burk
Publisher
214-394-3551
jburk@bmctoday.com

About Retina Today

Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight from well-respected specialists on cutting-edge therapies and surgical techniques that are currently in use and on the horizon.